Specifically, four abstracts will be presented at the meeting, which is scheduled for November 12-15. The following abstracts will be presented:
- Noninvasive muscle biomarkers predict all-cause mortality in nonalcoholic fatty liver disease.
- Radiomics-based coronary heart disease signature in liver transplant recipients with nonalcoholic fatty liver disease.
- Liver transplant recipients with nonalcoholic fatty liver disease have worse muscle composition profile.
- Natural rate of change in body composition on waitlist and the first 200 days after liver transplant.
Copyright © 2021 AuntMinnie.com